Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221194 · ClinicalTrials.gov registry record · NA
Therapeutic Stockings to Prevent Foot Ulcers
A NA study of Diabetes, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 381
- Enrollment target
- 4
- Study locations
NCT01221194: Completed NA study of Diabetes, sponsored by University of Texas Southwestern Medical Center.
NCT01221194 is a NA study of Diabetes that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 381 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01221194, a NA study of Diabetes, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 381 participants
- Enrollment target
- 4
- Study locations
Study Summary
1. To evaluate the efficacy of a therapeutic stockings (Protective Foot Care stockings, PFC) in reducing the incidence of diabetic foot pathology among high-risk patients. 2. To evaluate perceived health-related quality of life as compared to guideline directed usual care in patients who use the PFC stockings.
Primary Outcome
An ulceration will be defined as full thickness loss of epidermis and dermis or involvement of deeper structures.
Conditions Studied
Interventions
- BEHAVIORAL Standard therapy
- DEVICE PFC Stockings
Study Locations (4)
Texas
- Parkland Health & Hospital Systems - Dallas
- UT Southwestern Medical Center at Dallas - Dallas
- Scott & White - Temple
Other
- University of Manchester - Manchester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01221194 record still lists
NCT01221194 is an interventional study that assigns participants to a tested intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Standard therapy is the first listed.
NCT01221194 reports a single indexed study location in Texas, Other.
Frequently Asked Questions
What is clinical trial NCT01221194 about?
NCT01221194 is a clinical study titled "Therapeutic Stockings to Prevent Foot Ulcers". 1. To evaluate the efficacy of a therapeutic stockings (Protective Foot Care stockings, PFC) in reducing the incidence of diabetic foot pathology among high-risk patients. 2. To evaluate perceived health-related quality of life as compared to guideline directed usual care in patients who use the PFC...
What is the current status of trial NCT01221194?
This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2010-10. Estimated completion is 2016-03.
What conditions does trial NCT01221194 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT01221194?
The interventions under investigation include: Standard therapy (BEHAVIORAL), PFC Stockings (DEVICE).
Who is sponsoring clinical trial NCT01221194?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01221194 being conducted?
This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01221194's enrollment target sits among peer trials
381 92nd of 338 higher than 247 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia